Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 125, Issue 11, Pages 1651-1658Publisher
SPRINGER WIEN
DOI: 10.1007/s00702-018-1887-z
Keywords
MAO-B; Transgenic; Parkinson disease; Oxidative stress; Mitochondrial dysfunction; Neuroinflammation; Cellular senescence; Brain aging
Categories
Ask authors/readers for more resources
Several studies have suggested that increases in astrocytic monoamine oxidase B (MAO-B) levels in conjunction with Parkinson's disease (PD) may contribute to subsequent neuropathology associated with the disorder. MAO-B inhibitors are currently widely used as symptomatic therapeutics for PD and, although somewhat controversial, these drugs may also exhibit disease-modifying properties. To obtain a better understanding of the potential role of MAO-B in disease neuropathology, we created an inducible astrocyte-specific transgenic MAO-B mouse model. Here, we summarize findings associated with this model, including neuropathological PD features associated with it.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available